These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33542708)

  • 1. From Pituitary Stem Cell Differentiation to Regenerative Medicine.
    Camilletti MA; Martinez Mayer J; Vishnopolska SA; Perez-Millan MI
    Front Endocrinol (Lausanne); 2020; 11():614999. PubMed ID: 33542708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pituitary stem cells by epithelial to mesenchymal transition events and signaling pathways.
    Cheung LY; Davis SW; Brinkmeier ML; Camper SA; Pérez-Millán MI
    Mol Cell Endocrinol; 2017 Apr; 445():14-26. PubMed ID: 27650955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pituitary development and application of iPSCs for pituitary disease.
    Matsumoto R; Takahashi Y
    Cell Mol Life Sci; 2021 Mar; 78(5):2069-2079. PubMed ID: 33206204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making pituitary hormone-producing cells in a dish [Review].
    Suga H
    Endocr J; 2016 Aug; 63(8):669-80. PubMed ID: 27245938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induced pluripotent stem cells: a new paradigm to study human tissues].
    Sansac C; Assou S; Bouckenheimer J; Lemaître JM; De Vos J
    Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will it be possible to generate kidney tissue from induced pluripotent stem cells for regenerative therapy?
    Osafune K
    Regen Med; 2014 Jan; 9(1):9-12. PubMed ID: 24351001
    [No Abstract]   [Full Text] [Related]  

  • 8. Paired-related homeodomain proteins Prx1 and Prx2 are expressed in embryonic pituitary stem/progenitor cells and may be involved in the early stage of pituitary differentiation.
    Susa T; Kato T; Yoshida S; Yako H; Higuchi M; Kato Y
    J Neuroendocrinol; 2012 Sep; 24(9):1201-12. PubMed ID: 22577874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GRFa2/Prop1/stem (GPS) cell niche in the pituitary.
    Garcia-Lavandeira M; Quereda V; Flores I; Saez C; Diaz-Rodriguez E; Japon MA; Ryan AK; Blasco MA; Dieguez C; Malumbres M; Alvarez CV
    PLoS One; 2009; 4(3):e4815. PubMed ID: 19283075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Generation of Multiple Ocular Lineages from Human Pluripotent Stem Cells and Its Application to Regenerative Medicine].
    Hayashi R
    Yakugaku Zasshi; 2021; 141(1):55-60. PubMed ID: 33390448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells create a therapeutic niche.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.